ストックスクリーナーアプリを入手
1.015
1.00%
0.01
アフターアワーズ：
1.02
0.005
+0.49%
前日終値:
$1.005
開ける：
$1
24時間の取引高:
260.59K
Relative Volume:
1.03
時価総額：
$61.55M
収益：
$3.67M
当期純損益:
$-13.83M
株価収益率:
-3.625
EPS:
-0.28
ネットキャッシュフロー:
$-10.79M
1週間 パフォーマンス:
-3.33%
1か月 パフォーマンス:
-4.25%
6か月 パフォーマンス:
+23.78%
1年 パフォーマンス:
+37.16%
1日の値動き範囲:
$0.98
$1.0388
1週間の範囲:
$0.98
$1.0682
52週間の値動き範囲:
$0.48
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
ICCM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
1.015 | 61.55M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Icecure Medical Ltd (ICCM) 最新ニュース
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 - Investing.com Australia
IceCure Medical’s (ICCM) Buy Rating Reaffirmed at HC Wainwright - Defense World
Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market ... - Yahoo Finance
Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market Challenges - GuruFocus
ICCM: HC Wainwright & Co. Reiterates Buy Rating with $2.50 Price Target | ICCM Stock News - GuruFocus
IceCure Medical Ltd (NASDAQ:ICCM) Q1 2025 Earnings Call Transcript - Insider Monkey
IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch - MSN
IceCure Medical reports 2% revenue drop in Q1 2025 - Medical Buyer
IceCure Medical Reports Q1 2025 Financial Results - TipRanks
IceCure Medical’s Earnings Call: Optimism Amid Challenges - TipRanks
Transcript : IceCure Medical Ltd, Q1 2025 Earnings Call, May 28, 2025 - marketscreener.com
Icecure Medical Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Globe and Mail
IceCure (ICCM) Q1 2025 Earnings Call Transcript - The Motley Fool
IceCure Medical Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ICECURE MEDICAL Earnings Results: $ICCM Reports Quarterly Earnings - Nasdaq
IceCure Medical Reports First Quarter 2025 Financial Results - PR Newswire
Icecure Medical Ltd (ICCM) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 - Nasdaq
IceCure Medical Secures $2 Million Bridge Loan from Epoch - TipRanks
IceCure Medical Earnings: Cryoablation Pioneer Reports Q1 2025 Results May 28 - Stock Titan
IceCure Medical (ICCM) Expected to Announce Earnings on Tuesday - Defense World
IceCure Medical’s Shareholders Approve Key Agenda Items at Special Meeting - TipRanks
Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders - marketscreener.com
FY2025 EPS Estimates for IceCure Medical Boosted by Analyst - Defense World
IceCure Receives High Level of Interest from Breast Surgeons at - GuruFocus
IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PR Newswire
IceCure Medical Ltd (NASDAQ:ICCM) Shares Acquired by Geode Capital Management LLC - Defense World
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America - Barchart.com
IceCure Medical reports on FDA meeting for ProSense Cryoablation - TipRanks
ICCM Advances ProSense Approval with FDA Interface | ICCM Stock News - GuruFocus
IceCure Announces Positive FDA Development: Understanding on Pat - GuruFocus
IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PR Newswire
IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - GuruFocus
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems - marketscreener.com
Comparing Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) - Defense World
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - StreetInsider
IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation | ICCM Stock News - GuruFocus
IceCure Medical (NASDAQ:ICCM) Shares Down 3.1% – Time to Sell? - Defense World
IceCure Medical Announces Special Shareholder Meeting for May 2025 - TipRanks
FY2027 EPS Estimates for IceCure Medical Reduced by Analyst - Defense World
IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright - Defense World
Icecure Medical Ltd (ICCM) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):